Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Green Website

Jeffrey E. Green, M.D.

Selected Publications

1)  El Touny LH, Vieira A, Mendoza A, Khanna C, Hoenerhoff MJ, Green JE.
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.
J. Clin. Invest. 124: 156-68, 2014.
[Journal]
2)  Kim HK, Green JE.
Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agents.
Pharmacogenomics. 15: 375-84, 2014.
[Journal]
3)  Chu IM, Lai WC, Aprelikova O, El Touny LH, Kouros-Mehr H, Green JE.
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFß.
PLoS ONE. 8: e61125, 2013.
[Journal]
4)  Hu Y, Bai L, Geiger T, Goldberger N, Walker RC, Green JE, Wakefield LM, Hunter KW.
Genetic Background May Contribute to PAM50 Gene Expression Breast Cancer Subtype Assignments.
PLoS ONE. 8: e72287, 2013.
[Journal]
5)  Ahn SG, Dong SM, Oshima A, Kim WH, Lee HM, Lee SA, Kwon SH, Lee JH, Lee JM, Jeong J, Lee HD, Green JE.
LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients.
Breast Cancer Res. Treat. 141: 89-99, 2013.
[Journal]
6)  Bennett CN, Tomlinson CC, Michalowski AM, Chu IM, Luger D, Mittereder LR, Aprelikova O, Shou J, Piwinica-Worms H, Caplen NJ, Hollingshead MG, Green JE.
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
Breast Cancer Res. 14: R109, 2012.
[Journal]
7)  Chu IM, Michalowski AM, Hoenerhoff M, Szauter KM, Luger D, Sato M, Flanders K, Oshima A, Csiszar K, Green JE.
GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells.
Oncogene. 31: 2017-27, 2012.
[Journal]
8)  Paolicchi E, Crea F, Farrar WL, Green JE, Danesi R.
Histone lysine demethylases in breast cancer.
Crit. Rev. Oncol. Hematol. 86: 97-103, 2012.
[Journal]
9)  Aprelikova O, Green JE.
MicroRNA regulation in cancer-associated fibroblasts.
Cancer Immunol. Immunother. 61: 231-7, 2012.
[Journal]
10)  Switzer CH, Glynn SA, Cheng RY, Ridnour LA, Green JE, Ambs S, Wink DA.
S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer.
Mol. Cancer Res. 10: 1203-15, 2012.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/28/2014.